These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37662490)

  • 1. Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus.
    Miravitlles M; Acharya S; Aggarwal B; Fernandes FLA; Dreyse J; Jardim JR; Juthong S; Levy G; Sivori M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1853-1866. PubMed ID: 37662490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
    Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England.
    Rothnie KJ; Joksaite S; Sansbury LB; Compton C; Di Boscio V; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1455-1466. PubMed ID: 35769225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients.
    López-Campos JL; Alcázar Navarrete B; Riesco Miranda JA; Cosío BG; de-Torres JP; Celli B; Jiménez-Ruiz CA; Casanova Macario C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1801-1811. PubMed ID: 32884252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
    Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler
    Lin L; Liu C; Cheng W; Song Q; Zeng Y; Li X; Deng D; Liu D; Chen Y; Cai S; Chen P
    Front Pharmacol; 2023; 14():1147985. PubMed ID: 37025493
    [No Abstract]   [Full Text] [Related]  

  • 7. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).
    Deslee G; Fabry-Vendrand C; Poccardi N; Thabut G; Eteve Pitsaer C; Coriat A; Renaudat C; Maguire A; Pinto T
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37263738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study.
    Suehs CM; Zysman M; Chenivesse C; Burgel PR; Couturaud F; Deslee G; Berger P; Raherison C; Devouassoux G; Brousse C; Roche N; Molimard M; Chinet T; Devillier P; Chanez P; Kessler R; Didier A; Martinat Y; Le Rouzic O; Bourdin A
    BMJ Open; 2020 Jul; 10(7):e035811. PubMed ID: 32611741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population.
    Criner G; Martinez F; Gandhi H; Pyenson B; Feigler N; Emery M; Gupta U; Vaduganathan M
    J Health Econ Outcomes Res; 2023; 10(1):20-27. PubMed ID: 36742194
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD.
    Bourbeau J; Bafadhel M; Barnes NC; Compton C; Di Boscio V; Lipson DA; Jones PW; Martin N; Weiss G; Halpin DMG
    Int J Chron Obstruct Pulmon Dis; 2021; 16():499-517. PubMed ID: 33688176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.
    Miravitlles M; Marín A; Huerta A; Carcedo D; Villacampa A; Puig-Junoy J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1643-1654. PubMed ID: 32764910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
    Lee CH; Kim MS; Yeo SH; Rhee CK; Park HW; Yang BR; Lee J; Cho EY; Xu X; Navarro Rojas AA; Shantakumar S; Milea D; Choi NK
    Respir Res; 2022 Sep; 23(1):231. PubMed ID: 36064539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.
    Evans KA; Pollack M; Portillo E; Strange C; Touchette DR; Staresinic A; Patel S; Tkacz J; Feigler N
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1366-1377. PubMed ID: 36427341
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
    Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region.
    Resta E; Scioscia G; Lacedonia D; Quarato CMI; Panza F; Resta O; Lepore G; Buonamico E; Di Lecce V; Carpagnano GE; Barbaro MPF; Rossi N
    BMC Health Serv Res; 2022 Oct; 22(1):1283. PubMed ID: 36284319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation.
    Tkacz J; Evans KA; Touchette DR; Portillo E; Strange C; Staresinic A; Feigler N; Patel S; Pollack M
    Int J Chron Obstruct Pulmon Dis; 2022; 17():329-342. PubMed ID: 35177901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.
    Halpin DMG; Kendall R; Shukla S; Martin A; Shah D; Midwinter D; Beeh KM; Kocks JWH; Jones PW; Compton C; Risebrough NA; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2745-2755. PubMed ID: 36317185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
    Sansbury LB; Wood RP; Anley GA; Nam Y; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2795-2808. PubMed ID: 34675504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
    Suissa S; Dell'Aniello S; Ernst P
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.